Transfusion in trauma: thromboelastometry-guided coagulation factor concentrate-based therapy versus standard fresh frozen plasma-based therapy
- PMID: 21375741
- PMCID: PMC3219338
- DOI: 10.1186/cc10078
Transfusion in trauma: thromboelastometry-guided coagulation factor concentrate-based therapy versus standard fresh frozen plasma-based therapy
Abstract
Introduction: Thromboelastometry (TEM)-guided haemostatic therapy with fibrinogen concentrate and prothrombin complex concentrate (PCC) in trauma patients may reduce the need for transfusion of red blood cells (RBC) or platelet concentrate, compared with fresh frozen plasma (FFP)-based haemostatic therapy.
Methods: This retrospective analysis compared patients from the Salzburg Trauma Centre (Salzburg, Austria) treated with fibrinogen concentrate and/or PCC, but no FFP (fibrinogen-PCC group, n = 80), and patients from the TraumaRegister DGU receiving ≥ 2 units of FFP, but no fibrinogen concentrate/PCC (FFP group, n = 601). Inclusion criteria were: age 18-70 years, base deficit at admission ≥ 2 mmol/L, injury severity score (ISS) ≥ 16, abbreviated injury scale for thorax and/or abdomen and/or extremity ≥ 3, and for head/neck < 5.
Results: For haemostatic therapy in the emergency room and during surgery, the FFP group (ISS 35.5 ± 10.5) received a median of 6 units of FFP (range: 2, 51), while the fibrinogen-PCC group (ISS 35.2 ± 12.5) received medians of 6 g of fibrinogen concentrate (range: 0, 15) and 1200 U of PCC (range: 0, 6600). RBC transfusion was avoided in 29% of patients in the fibrinogen-PCC group compared with only 3% in the FFP group (P< 0.001). Transfusion of platelet concentrate was avoided in 91% of patients in the fibrinogen-PCC group, compared with 56% in the FFP group (P< 0.001). Mortality was comparable between groups: 7.5% in the fibrinogen-PCC group and 10.0% in the FFP group (P = 0.69).
Conclusions: TEM-guided haemostatic therapy with fibrinogen concentrate and PCC reduced the exposure of trauma patients to allogeneic blood products.
Figures



Comment in
-
Which is the most effective strategy: early detection of coagulopathy with thromboelastometry or use of hemostatic factors or both?Crit Care. 2011;15(3):433; author reply 433. doi: 10.1186/cc10224. Epub 2011 Jun 13. Crit Care. 2011. PMID: 21672283 Free PMC article. No abstract available.
Similar articles
-
Impact of fibrinogen concentrate alone or with prothrombin complex concentrate (+/- fresh frozen plasma) on plasma fibrinogen level and fibrin-based clot strength (FIBTEM) in major trauma: a retrospective study.Scand J Trauma Resusc Emerg Med. 2013 Oct 8;21:74. doi: 10.1186/1757-7241-21-74. Scand J Trauma Resusc Emerg Med. 2013. PMID: 24103457 Free PMC article.
-
Goal-directed coagulation management of major trauma patients using thromboelastometry (ROTEM)-guided administration of fibrinogen concentrate and prothrombin complex concentrate.Crit Care. 2010;14(2):R55. doi: 10.1186/cc8948. Epub 2010 Apr 7. Crit Care. 2010. PMID: 20374650 Free PMC article.
-
Four-factor prothrombin complex concentrate is associated with improved survival in trauma-related hemorrhage: A nationwide propensity-matched analysis.J Trauma Acute Care Surg. 2019 Aug;87(2):274-281. doi: 10.1097/TA.0000000000002262. J Trauma Acute Care Surg. 2019. PMID: 30889141
-
Roles of thrombelastography and thromboelastometry for patient blood management in cardiac surgery.Transfus Med Rev. 2013 Oct;27(4):213-20. doi: 10.1016/j.tmrv.2013.08.004. Epub 2013 Sep 26. Transfus Med Rev. 2013. PMID: 24075802 Review.
-
Immediate Higher-Dose Prothrombin Complex Concentrate Without Fresh Frozen Plasma or Fibrinogen Concentrate for Significant Coagulopathic Cardiac Surgical Field Bleeding.Heart Lung Circ. 2022 Sep;31(9):1300-1306. doi: 10.1016/j.hlc.2022.05.048. Epub 2022 Jul 15. Heart Lung Circ. 2022. PMID: 35843859 Review.
Cited by
-
Thromboelastometry and organ failure in trauma patients: a prospective cohort study.Crit Care. 2014 Dec 25;18(6):687. doi: 10.1186/s13054-014-0687-6. Crit Care. 2014. PMID: 25539910 Free PMC article.
-
Ultramassive transfusion and adjunctive therapies in a case of blood bank depletion.Trauma Case Rep. 2023 Oct 18;48:100955. doi: 10.1016/j.tcr.2023.100955. eCollection 2023 Dec. Trauma Case Rep. 2023. PMID: 37955000 Free PMC article.
-
Trauma-induced coagulopathy: impact of the early coagulation support protocol on blood product consumption, mortality and costs.Crit Care. 2015 Mar 12;19(1):83. doi: 10.1186/s13054-015-0817-9. Crit Care. 2015. PMID: 25880548 Free PMC article.
-
Hemostatic effect of fibrinogen concentrate on traumatic massive hemorrhage: a propensity score matching study.Trauma Surg Acute Care Open. 2024 Jan 30;9(1):e001271. doi: 10.1136/tsaco-2023-001271. eCollection 2024. Trauma Surg Acute Care Open. 2024. PMID: 38298819 Free PMC article.
-
The European guideline on management of major bleeding and coagulopathy following trauma: sixth edition.Crit Care. 2023 Mar 1;27(1):80. doi: 10.1186/s13054-023-04327-7. Crit Care. 2023. PMID: 36859355 Free PMC article. Review.
References
-
- Rossaint R, Bouillon B, Cerny V, Coats TJ, Duranteau J, Fernandez-Mondejar E, Hunt BJ, Komadina R, Nardi G, Neugebauer E, Ozier Y, Riddez L, Schultz A, Stahel PF, Vincent JL, Spahn DR. Management of bleeding following major trauma: an updated European guideline. Crit Care. 2010;14:R52. doi: 10.1186/cc8943. - DOI - PMC - PubMed
-
- Holcomb JB, Jenkins D, Rhee P, Johannigman J, Mahoney P, Mehta S, Cox ED, Gehrke MJ, Beilman GJ, Schreiber M, Flaherty SF, Grathwohl KW, Spinella PC, Perkins JG, Beekley AC, McMullin NR, Park MS, Gonzalez EA, Wade CE, Dubick MA, Schwab CW, Moore FA, Champion HR, Hoyt DB, Hess JR. Damage control resuscitation: directly addressing the early coagulopathy of trauma. J Trauma. 2007;62:307–310. doi: 10.1097/TA.0b013e3180324124. - DOI - PubMed
-
- Borgman MA, Spinella PC, Perkins JG, Grathwohl KW, Repine T, Beekley AC, Sebesta J, Jenkins D, Wade CE, Holcomb JB. The ratio of blood products transfused affects mortality in patients receiving massive transfusions at a combat support hospital. J Trauma. 2007;63:805–813. doi: 10.1097/TA.0b013e3181271ba3. - DOI - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical